Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

661 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Human Leukocyte Antigen Allele-Killer Cell Immunoglobulin-like Receptor Partners on Sexually Transmitted Human Immunodeficiency Virus Type 1 Infection.
Serrano-Rísquez C, Omar M, Rallón N, Benito JM, Gómez-Vidal A, Márquez FJ, Alján M, Rivero-Juárez A, Pérez-Valero I, Rivero A, Sinangil F, Saulle I, Biasin M, Clerici M, Forthal D, Saéz ME, Caruz A. Serrano-Rísquez C, et al. Among authors: rivero a. J Infect Dis. 2024 Nov 15;230(5):e1077-e1081. doi: 10.1093/infdis/jiae436. J Infect Dis. 2024. PMID: 39208444 Free PMC article.
Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression.
Mira JA, Gutiérrez-Valencia A, Gil Ide L, Merino D, Rivero A, Ríos-Villegas MJ, Delgado M, González-Serrano M, Collado A, Torres-Tortosa M, Omar M, López-Ruz MA, Macías J, Arponen S, Pineda JA. Mira JA, et al. Among authors: rivero a. Clin Infect Dis. 2009 Oct 15;49(8):e84-91. doi: 10.1086/605677. Clin Infect Dis. 2009. PMID: 19772388
Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin.
Macías J, del Valle J, Rivero A, Mira JA, Camacho A, Merchante N, Pérez-Camacho I, Neukam K, Rivero-Juárez A, Mata R, Torre-Cisneros J, Pineda JA; Grupo para el Estudio de las Hepatitis Víricas de la Sociedad Andaluza de Enfermedades Infecciosas. Macías J, et al. Among authors: rivero a, rivero juarez a. J Antimicrob Chemother. 2010 Oct;65(10):2204-11. doi: 10.1093/jac/dkq272. Epub 2010 Jul 22. J Antimicrob Chemother. 2010. PMID: 20656678
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.
Medrano J, Neukam K, Rallón N, Rivero A, Resino S, Naggie S, Caruz A, Calvino A, Macías J, Benito JM, Sánchez-Piedra C, Vispo E, Barreiro P, McHutchison J, Pineda JA, Soriano V. Medrano J, et al. Among authors: rivero a. Clin Infect Dis. 2010 Nov 15;51(10):1209-16. doi: 10.1086/656811. Clin Infect Dis. 2010. PMID: 20964522
Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients.
Rivero-Juárez A, Mira JA, Pérez-Camacho I, Macías J, Camacho A, Neukam K, Torre-Cisneros J, Merchante N, Pineda JA, Rivero A; Viral Hepatitis Study Group, part of the Sociedad Andaluza de Enfermedades Infecciosas (SAEI) (Andalusian Society for Infectious Diseases). Rivero-Juárez A, et al. Among authors: rivero a. J Antimicrob Chemother. 2011 Jun;66(6):1351-3. doi: 10.1093/jac/dkr091. Epub 2011 Mar 17. J Antimicrob Chemother. 2011. PMID: 21415037
Present-day treatment of tuberculosis and latent tuberculosis infection.
Pérez-Camacho I, Rivero-Juárez A, Kindelán JM, Rivero A. Pérez-Camacho I, et al. Among authors: rivero a, rivero juarez a. Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 1:41-6. doi: 10.1016/S0213-005X(11)70017-9. Enferm Infecc Microbiol Clin. 2011. PMID: 21420566 Review.
Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
Barreiro P, Pineda JA, Rallón N, Naggie S, Martín-Carbonero L, Neukam K, Rivero A, Benito JM, Caruz A, Vispo E, Camacho A, Medrano J, McHutchison J, Soriano V. Barreiro P, et al. Among authors: rivero a. J Infect Dis. 2011 Jun 1;203(11):1629-36. doi: 10.1093/infdis/jir113. J Infect Dis. 2011. PMID: 21592993
661 results